- Home
- ELTX vs CURR Comparison
ELTX vs CURR Comparison
Compare ELTX & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- CURR
- Stock Information
- Founded
- ELTX 2011
- CURR 2013
- Country
- ELTX United States
- CURR Singapore
- Employees
- ELTX N/A
- CURR N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- CURR Business Services
- Sector
- ELTX Health Care
- CURR Consumer Discretionary
- Exchange
- ELTX Nasdaq
- CURR Nasdaq
- Market Cap
- ELTX 158.5M
- CURR 151.4M
- IPO Year
- ELTX N/A
- CURR N/A
- Fundamental
- Price
- ELTX $9.13
- CURR $2.95
- Analyst Decision
- ELTX Strong Buy
- CURR Strong Buy
- Analyst Count
- ELTX 1
- CURR 1
- Target Price
- ELTX $13.00
- CURR $3.50
- AVG Volume (30 Days)
- ELTX 102.3K
- CURR 2.1M
- Earning Date
- ELTX 11-07-2025
- CURR 11-05-2025
- Dividend Yield
- ELTX N/A
- CURR N/A
- EPS Growth
- ELTX N/A
- CURR N/A
- EPS
- ELTX N/A
- CURR N/A
- Revenue
- ELTX N/A
- CURR $41,092,419.00
- Revenue This Year
- ELTX N/A
- CURR N/A
- Revenue Next Year
- ELTX N/A
- CURR $14.56
- P/E Ratio
- ELTX N/A
- CURR N/A
- Revenue Growth
- ELTX N/A
- CURR N/A
- 52 Week Low
- ELTX $4.60
- CURR $0.33
- 52 Week High
- ELTX $12.62
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- ELTX 34.25
- CURR 61.51
- Support Level
- ELTX $9.03
- CURR $1.69
- Resistance Level
- ELTX $9.55
- CURR $4.68
- Average True Range (ATR)
- ELTX 0.46
- CURR 0.57
- MACD
- ELTX -0.04
- CURR 0.10
- Stochastic Oscillator
- ELTX 9.65
- CURR 43.83
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.